Caroline Kruse Named President and CEO of the Platelet Disorder Support Association
- 22 October 2018 |
ITP in the News
Principia Biopharma Announces PRN1008 Receives Orphan-Drug Designation from FDA for Treatment of Immune Thrombocytopenic Purpura
- 19 October 2018 |
How patients are helping drive research and drug development
- 17 October 2018 |
Texas Children’s hematologists contribute to leading textbook in field
- 12 October 2018 |
Five-year-old Wrexham boy with unusual and rare disease takes part in photo project to raise awareness
- 04 October 2018 |
Sara's story: A blessing in disguise
- 02 October 2018 |
Paying Attention to the signals: 23-year-old SCV resident searching for liver-transplant donor
- 24 September 2018 |
Sanofi’s Cablivi cleared for rare bleeding disorder (TTP)
- 10 September 2018 |
How can I increase my platelet count naturally?
- 10 September 2018 |
Retired teacher and 10-year-old girl form special bond during medical treatments
- 04 September 2018 |
Novartis’ severe aplastic anaemia drug fast-tracked by FDA
- 04 June 2018 |
Allegheny County settles with parents improperly accused of child abuse
- 07 February 2018 |
Former ‘Tenors’ Singer Remigio Pereira Reveals Health Scare, Shares Update With Fans
- 08 October 2017 |
Red Deer’s Canadian Blood Services saves lives
- 26 September 2017 |
Cayden, ITP patient, recognized at Green Bay Packers' game
- 22 September 2017 |
Splenectomy vs. rituximab as a second-line therapy in immune thrombocytopenic purpura: a single center experience
- 22 September 2017 |
argenx reaches 50% enrollment in Phase 2 clinical trial of ARGX-113 in immune thrombocytopenia
- 22 September 2017 |
Novartis’ Revolade proved effective for seniors
- 11 September 2017 |
Protalex Doses First Patient in Third Cohort of European Phase 1b Study of PRTX-100 in ITP
- 05 September 2017 |
Role of Polymorphisms in Idiopathic Thrombocytopenic Purpura: A Review
- 05 September 2017 |
Quick Consult: Symptom: Arm and Back Rash
- 05 September 2017 |
Mum’s heartbreak at having to ban her five-year-old daughter from playing with her friends
- 21 August 2017 |
Protalex Completes Data Analysis of Second Dose Cohort of U.S. Phase 1/2 Study of PRTX-100 in ITP
- 02 August 2017 |
Oklahoma researchers zero in on cause of blood disorder
- 31 July 2017 |
FDA Accepts New Drug Application for Chronic ITP Treatment
- 22 June 2017 |
Weill Cornell team creates breakthrough on blood disorders
- 10 June 2017 |
Bishop Sutton student's warrior spirit
- 16 May 2017 |
